Success Metrics

Clinical Success Rate
50.0%

Based on 5 completed trials

Completion Rate
50%(5/10)
Active Trials
1(7%)
Results Posted
100%(5 trials)
Terminated
5(33%)

Phase Distribution

Ph early_phase_1
2
13%
Ph not_applicable
6
40%
Ph phase_2
1
7%
Ph phase_1
2
13%
Ph phase_3
2
13%

Phase Distribution

4

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
2(15.4%)
Phase 1Safety & dosage
2(15.4%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
2(15.4%)
N/ANon-phased studies
6(46.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

38.5%

5 of 13 finished

Non-Completion Rate

61.5%

8 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(5)
Terminated(8)

Detailed Status

Terminated5
Completed5
Withdrawn3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (15.4%)
Phase 12 (15.4%)
Phase 21 (7.7%)
Phase 32 (15.4%)
N/A6 (46.2%)

Trials by Status

terminated533%
completed533%
recruiting17%
withdrawn320%
not_yet_recruiting17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07356349Phase 3

Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE Use Disorder (ATTESTED)

Not Yet Recruiting
NCT05850520Phase 3

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

Completed
NCT05556525Not Applicable

Needle-Based Confocal Laser Endomicroscopy for Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules

Terminated
NCT02691923Phase 2

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Recruiting
NCT01034670Not Applicable

Advanced Gastrointestinal Endoscopic Imaging

Terminated
NCT03220711Not Applicable

Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon

Terminated
NCT03658551

Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy

Terminated
NCT01979003Early Phase 1

Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion

Completed
NCT04687488Not Applicable

Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations

Completed
NCT02389530

Use of Fluorescein Dye for the Removal of Brain Tumors

Completed
NCT02540135Not Applicable

Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma

Withdrawn
NCT02703558Not Applicable

Evaluation of Fluorescein Use During Cystoscopy

Withdrawn
NCT00847522Phase 1

Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma

Completed
NCT01384695Early Phase 1

A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1

Terminated
NCT01614184Phase 1

Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer

Withdrawn

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15